Coherus Oncology Inc
F:8C5
Coherus Oncology Inc
F:8C5
Price:
0.9485
EUR
6.51%
Market Cap:
€108.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Coherus Oncology Inc
F:8C5
|
US |
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
P
|
PDF Solutions Inc
F:PD9
|
US |
|
LifeVantage Corp
NASDAQ:LFVN
|
US |
|
Advantest Corp
TSE:6857
|
JP |
|
B
|
BP PLC
DUS:BPE5
|
UK |
|
D
|
Deutsche Telekom AG
SWB:DTEA
|
DE |
|
Renew Holdings PLC
F:LLP
|
UK |
|
P
|
Planktos Corp
OTC:PLKT
|
US |
|
Sofina SA
XBRU:SOF
|
BE |
|
W
|
WSP Global Inc
F:1W3
|
CA |
|
C
|
Citigroup Inc
XHAM:TRVC
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
I
|
Ilji Technology Co Ltd
KOSDAQ:019540
|
KR |
|
Malteries Franco Belges SA
PAR:MALT
|
FR |
|
Ship Healthcare Holdings Inc
F:5EZ
|
JP |
|
Ternium SA
NYSE:TX
|
LU |
|
B
|
Black Mammoth Metals Corp
OTC:LQRCF
|
CA |
Multiples-Based Value
The Multiples-Based Value for 
Coherus Oncology Inc (8C5) under the Base Case is hidden
EUR.
Compared with the current market price of 0.9485 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
8C5 Multiples-Based Value
LOCKED